Global Immunoglobulins Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Immunoglobulins Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen.
Immunoglobulins report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immunoglobulins market is projected to reach US$ 13870 million in 2034, increasing from US$ 10450 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2034. Demand from Hospital and Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Immunoglobulins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Immunoglobulins key manufacturers include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics, and BioScrip, etc. Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH are top 3 players and held % sales share in total in 2022.
Immunoglobulins can be divided into IgG, IgA, IgM and IgE, etc. IgG is the mainstream product in the market, accounting for % sales share globally in 2022.
Immunoglobulins is widely used in various fields, such as Hospital and Research, etc. Hospital provides greatest supports to the Immunoglobulins industry development. In 2022, global % sales of Immunoglobulins went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunoglobulins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip
Segment by Type
IgG
IgA
IgM
IgE
IgD
Hospital
Research
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Immunoglobulins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Immunoglobulins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Immunoglobulins industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Immunoglobulins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Immunoglobulins introduction, etc. Immunoglobulins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Immunoglobulins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Immunoglobulins report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immunoglobulins market is projected to reach US$ 13870 million in 2034, increasing from US$ 10450 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2034. Demand from Hospital and Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Immunoglobulins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Immunoglobulins key manufacturers include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics, and BioScrip, etc. Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH are top 3 players and held % sales share in total in 2022.
Immunoglobulins can be divided into IgG, IgA, IgM and IgE, etc. IgG is the mainstream product in the market, accounting for % sales share globally in 2022.
Immunoglobulins is widely used in various fields, such as Hospital and Research, etc. Hospital provides greatest supports to the Immunoglobulins industry development. In 2022, global % sales of Immunoglobulins went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunoglobulins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip
Segment by Type
IgG
IgA
IgM
IgE
IgD
Segment by Application
Hospital
Research
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Immunoglobulins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Immunoglobulins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Immunoglobulins industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Immunoglobulins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Immunoglobulins introduction, etc. Immunoglobulins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Immunoglobulins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices